MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Is J&J in the hunt for Boston Scientific? | Acquisitions Roundup

Is J&J in the hunt for Boston Scientific? | Acquisitions Roundup

By

Johnson & Johnson
Boston Scientific

Could the amicable deal between bitter rivals Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) over Michael Mahoney leaving J&J to helm BSX signal an upcoming acquisition?

Opinions are divided on Wall Street, with at least one analyst wondering if a deal could be in the works and others casting doubt on the speculation.

In a late-breaking announcement Sept. 13, Boston Scientific said Mahoney will become president effective Oct. 17 and take the corner office in November 2012. The unusual transition period allows Mahoney to learn the business and also helps side-step any anti-competition covenants in his contract with J&J. The news came as a surprise given the duo’s long-standing battles over the drug-eluting coronary stent market, which Johnson & Johnson pioneered – only to see BSX emerge with the leading market share.

Sign up to get our free newsletters delivered right to your inbox

The amity might indicate that J&J is ultimately interested in buying its smaller peer, according to Wells Fargo analyst Larry Biegelsen. The "friendly agreement" that’s sending Mahoney to BSX’s Natick, Mass. HQ could "fuel additional speculation" that a merger is afoot, Biegelsen wrote in a note to investors yesterday.

Other analysts on The Street were not so sure.

"An interesting theory but sounds like pure speculation," Sanford Bernstein analyst Derrick Sung told the Wall Street Journal, adding that Mahoney got the job for his willingness to continue the turnaround plan put in place by the man he’s succeeding, Ray Elliott.

“The last thing you want is a new CEO coming in who says, ‘I’m the new CEO, I’m going to blow up this plan,'” Elliott told analysts yesterday at the Morgan Stanley Global Health Conference in New York. "Mike was essentially, from very early in the game, almost a perfect match – and that’s culturally, too."

Another un-named analyst told the Journal that J&J isn’t interested in acquiring Boston Scientific and that Mahoney is leaving Johnson & Johnson on less-than-friendly terms.

But if J&J isn’t interested in Boston Scientific, it is interested in broadening its portfolio of cardiac devices to include heart pumps and heart valves, according to CFO Dominic Caruso.

“Both [technologies] are interesting. We are interested in looking at them,” Caruso said at the conference Sept. 13. “Unfortunately they are overvalued today.”

That could make targets of heart pump makers Abiomed Inc. (NSDQ:ABMD), HeartWare International (NSDQ:HTWR), Thoratec Corp. (NSDQ:THOR) and World Heart Corp. (NSDQ:WHRT) on the cardiac assist device side. Here’s a look at how each company shapes up in terms of price/earnings ratio:


Company Price EPS P/E
Abiomed $11.23 -$0.28 -40
HeartWare $55.73 -$2.48 -22
Thoratec $31.40 $1.07 29
World Heart $0.43 -$0.32 -1.34

By this measure, J&J would have to put some of its slaes muscle behind Abiomed, Thoratec is an expensive purchase for J&J (by way of comparison, the Dow Jones medical device index has a P/E ratio of 3.2), which is making price one of its top considerations, according to finance chief Caruso. But with their earnings under water, J&J would have to spend on R&D and put its sales and marketing muscle behind the heart pumps made by the other three firms.

And J&J’s penchant for low pricing could make a deal for Edwards Lifesciences (NSDQ:EW) less palatable too, even though the heart valve pioneer is leading the race to bring the first catheter-delivered replacement aortic valve to the U.S. market. Here’s a look at the P/E ratios of Edwards and other heart valve makers:


Company Price EPS P/E
Abbott $51.05 $3.28 16
Edwards $76.25 $1.96 39
Medtronic $34.20 $2.87 12
St. Jude Medical $43.43 $2.68 16

Another name to put into the heart valve mix is privately owned On-X Life Technologies, which won 510(k) clearance in January for a version of its ascending aortic prosthesis valve.

Here’s a roundup of other merger & acquisition news

Mergers and Acquisitions

In case you missed it

RSS From Medical Design & Outsourcing

  • CVRx CEO Nadim Yared suggests steps toward improving diversity and equality
    In this week’s episode of DeviceTalks Weekly, we follow up with last week’s guest, Nadim Yared, CEO of CVRx, to catch up on how the medtech executive is managing during the pandemic. Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide… […]
  • Ogura Industrial touts holding brakes for robotic and medical equipment
    As automation continues to accelerate, there’s a growing need to hold equipment in place in the case of a power failure — or to provide positioning, according to Ogura Industrial, maker of six different styles of holding brakes. With roughly 120 standard models, key features of Ogura Industrial’s holding brake families include brake diameters down… […]
  • What kinds of COVID-19 tests are out there?
    Months into the pandemic, the FDA continues to grant emergency use approval (EUA) to new tests to detect the virus that causes COVID-19 and the antibodies that indicate a person has had it. To date, the FDA has granted EUAs for 171 tests —142 molecular tests, 27 antibody tests, and 2 antigen tests. Given the ever-changing… […]
  • FDA plans to resume onsite inspections later this month
    FDA has a goal of restarting on-site inspections during the week of July 20 — four months after it temporarily halted them — though there will be changes due to the COVID-19 pandemic. The agency today said that it will pre-announce inspections to FDA-regulated businesses. Said FDA: “This will help assure the safety of the… […]
  • Formlabs announces new biocompatible, medical-grade resins
    Formlabs, the Somerville, Mass.–based maker of 3D printers, recently announced six new materials across its Form 3, Form 3B, and Form 2 SLA 3D printers — including two new biocompatible, medical-grade resins. The new material families and resins are meant to provide more options for designers and engineers in fields including: Healthcare — with a… […]
  • Magnolia Medical launches Steripath Gen2 with integrated syringe
    Magnolia Medical this week said it launched its Steripath Gen2 Initial Specimen Diversion Device with an integrated syringe. The device is designed for reducing blood culture contamination in “hard stick” patients and syringe collection protocols. Steripath Gen2 features an integrated syringe that addresses difficult intravenous access. It offers precise control to carefully collect blood samples.… […]
  • How Frankenstein sparked Earl Bakken’s love of medical devices
    When the late Medtronic founder Earl Bakken first watched the classic horror movie “Frankenstein” in the 1930s, it did more than just scare: It inspired. “What intrigued me the most as I sat through the movie again and again, was the creative spark of Dr. Frankenstein’s electricity,” Bakken said in his 1990 autobiography “One Man’s… […]
  • Boston researchers have created a potential N95 mask alternative
    Brigham & Women’s Hospital says it is developing a new, sustainable alternative to N95 respirator masks that are in demand during the COVID-19 pandemic. A team of bioengineers and clinical experts at the Boston-based hospital and the Massachusetts Institute of Technology (MIT) are working on the “injection molded autoclavable, scalable, conformable” iMASC system for providing… […]
  • MIT researchers think they’ve found a way to get more particles through a syringe
    Researchers at the Massachusetts Institute of Technology (MIT) are touting a computational model that could prevent microparticle clogging during injections. Microparticles, which are about the size of a grain of sand, can be difficult to inject if they get clogged in a typical syringe. The research team at MIT developed this new model that determines… […]
  • Fotofab adds direct-imaging machine for chemical etching
    Fotofab announced this week that it has acquired a new Chime Ball Technologies direct-imaging (DI) machine from Technica, USA to optimize its chemical etching process and provide a more advanced level of precision and speed for thin metal parts. The DI machine has CBT’s patented finger-print technology with LED lighting that enables Fotofab to directly… […]
  • Could this heated air filter help fight COVID-19?
    University of Houston researchers and medical real estate development firm Medistar claim that they’ve designed an air filter that can catch and instantly kill the virus that causes COVID-19. Galveston National Laboratory tests on the filter found it killed 99.8% of SARS-CoV-2 virus in a single pass — as well as 99.9% of anthrax spores,… […]

Leave a Reply

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube